|
Printable version |
From: | "Lazy Haggis" <lazyhaggis@hotmail.com> |
Date: | Sun, 18 Apr 2004 19:46:05 +0000 |
Latest April 04 Aegis Equities Comments. Through the acquisition of Visiomed AG, VSG has not only secured full control over the microDERM device but also has rights to any other IP developed within the German company. This includes some interesting surgical navigation technology that VSG may be able to commercialise in the future. The Funhaler provides a potential spinout product that can help fund VSG's other ventures. VSG has managed to build its patent portfolio over the last year, an important first step to eventual commercialisation. A recent study was published in the influential British Journal of Dermatology detailing the diagnostic use of the MicroDERM system and this should help it achieve US regulatory approval as higher value diagnostic device. VSG also forged closer links with Siemens AG, one of the world's largest and most recognised engineering and medical imaging companies, announcing an exclusive Australian dealership for a range of Siemens medical imaging systems. VSG is also a significant participating collaborator with Siemens in the development of ultrasound-based surgical navigation systems for spinal procedures. Lazy Haggis _________________________________________________________________ Watch LIVE baseball games on your computer with MLB.TV, included with MSN Premium! http://join.msn.com/?page=features/mlb&pgmarket=en-us/go/onm00200439ave/direct/01/ ---------------------------------------------------------------------------- To remove yourself from this list, please use the form at http://www.sharechat.co.nz/chat/forum/
Replies
|